MetaCap

Health ETFs

44 health ETFs ranked by assets under management. Updated October 10, 2026.

Total assets
$91.8B

MetaCap lists 44 US-listed ETFs in the Health category, holding a combined $91.8B in assets. The largest by assets are XLV ($43.4B), IBB ($11.2B) and XBI ($10.4B). Expense ratios range from 0.08% to 2.56% (median 0.47%); XLV is the lowest-cost fund shown at 0.08% a year. On the latest trading day, 43 of 44 funds were higher, with an average move of +2.15%.

Summary generated from market data by MetaCap's automated system. Methodology

Largest health ETFs by assets

Health ETFs by assets under management
#SymbolFund NamePrice% ChangeAUM
1XLVState Street Health Care Select Sector SPDR ETF170.81+1.58%$43.39B
2IBBiShares Biotechnology ETF206.49+3.00%$11.20B
3XBIState Street SPDR S&P Biotech ETF153.77+3.00%$10.36B
4IXJiShares Global Healthcare ETF103.17+1.37%$4.32B
5FHLCFidelity MSCI Health Care Index ETF82.45+1.61%$3.54B
6IHIiShares U.S. Medical Devices ETF51.74+1.25%$3.45B
7FBTFirst Trust Amex Biotech Index Fund265.40+2.00%$2.97B
8ARKGARK Genomic Revolution ETF51.30+4.08%$2.22B
9IHEiShares U.S. Pharmaceutical ETF100.09+1.24%$1.63B
10IHFiShares U.S. Health Care Providers ETF56.76+1.74%$1.36B
11FTXHFirst Trust Nasdaq Pharmaceuticals ETF41.27+2.03%$1.06B
12PBPHPortfolio Building Block World Pharma and Biotech Index ETF28.36+1.38%$1.05B
13PPHVanEck Pharmaceutical ETF110.49+1.20%$1.02B
14PJPInvesco Pharmaceuticals ETF122.88+1.56%$557.24M
15XPHState Street SPDR S&P Pharmaceuticals ETF64.65+1.60%$523.98M
16BBHVanEck Biotech ETF240.47+2.85%$487.74M
17PBEInvesco Biotechnology & Genome ETF96.90+2.80%$423.52M
18PTHInvesco Dorsey Wright Healthcare Momentum ETF58.76+2.45%$366.97M
19PINKSimplify Health Care ETF38.53+2.57%$348.96M
20IDNAiShares Genomics Immunology and Healthcare ETF42.17+4.33%$298.98M
21XHSState Street SPDR S&P Health Care Services ETF136.03+1.05%$218.48M
22CANCTema Oncology ETF40.78+1.50%$208.60M
23BBPVirtus Biotech ETF104.76+3.48%$131.53M
24LFSCF/m Emerald Life Sciences Innovation ETF42.61+2.71%$123.35M
25IBBQInvesco Nasdaq Biotechnology ETF34.62+3.01%$103.28M
26GNOMGlobal X Genomics & Biotechnology ETF68.75+4.44%$102.88M
27SURISimplify Propel Opportunities ETF17.22+0.78%$76.30M
28OZEMRoundhill GLP-1 & Weight Loss ETF29.60+1.20%$57.76M
29HRTSTema Heart & Health ETF36.22+1.87%$53.71M
30FMEDFidelity Disruptive Medicine ETF31.40+3.19%$52.31M
31MEDIHarbor Health Care ETF32.46+1.75%$41.69M
32TMEDT. Rowe Price Health Care ETF33.81+3.33%$33.01M
33GDOCGoldman Sachs Future Health Care Equity ETF36.50+1.53%$19.48M
34BMEDiShares Health Innovation Active ETF34.34+2.04%$13.80M
35IBRNiShares Neuroscience and Healthcare ETF31.75+1.15%$6.65M
36WDNAWisdomTree BioRevolution Fund23.50+3.98%$4.80M
37EKGFirst Trust Nasdaq Lux Digital Health Solutions ETF23.42+3.30%$4.74M
38NVOHNovo Nordisk A/S B Shares ADRhedged21.79+0.54%$3.60M
39GNMXCorgi Genomics & Precision Medicine ETF37.52+3.90%$2.87M
40LGHTLangar Global HealthTech ETF10.81+3.52%$2.40M
41MHIPMilliman Healthcare Inflation Plus ETF20.84+1.11%$1.55M
42ASDDefiance Autism Impact ETF26.62+0.62%$1.34M
43GSKHGSK plc ADRhedged66.29-0.10%$682.76K
44TRUHVanEck Healthcare TruSector ETF29.78+1.11%$589.45K

Frequently asked questions

How many health ETFs are there?
MetaCap tracks 44 US-listed health ETFs with about $91.8B in combined assets.
What is the largest health ETF?
State Street Health Care Select Sector SPDR ETF (XLV) is the largest, with about $43.4B in assets under management.
Which Health ETF has the lowest expense ratio?
Among the funds shown, State Street Health Care Select Sector SPDR ETF (XLV) has the lowest expense ratio at 0.08% per year, or $8 a year on a $10,000 investment.
What does AUM mean for an ETF?
Assets under management (AUM) is the total market value of everything the fund holds. Larger ETFs tend to have tighter bid-ask spreads and more trading volume, but size alone does not make a fund a better investment.

Explore more ETFs

Prices as of Oct 10, 4:50 AM EDT. Market data is delayed at least 15 minutes and provided for informational purposes only. Not investment advice. Full disclaimer